مباشر

Endpoints NewsNovo vet Uli Stilz settles in at Flagship; Revolution Medicines welcomes commercial exec BioPharma DivePharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?Lonza NewsStipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter CellSingle-cell mapping of regulatory DNA-protein interactions CellPlasma signals of lung tumor promotion for molecular cancer prevention CellDeep learning of functional perturbations from condensate morphology FierceBiotechAt first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts Lonza NewsStipple Bio taps Lonza platform to advance ADC pipeline - The Pharma Letter 10x Genomics Blog10x Genomics Stock On Fire: Up 41% With 8-Day Winning Streak - Trefis LabiotechEpisode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media Lonza NewsLonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies - Indian Pharma Post Eli LillyGilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSN

Roche Media ١ ديسمبر ٢٠٢٥

YuviTal wins Roche-backed breast cancer innovation challenge - JNS.org

YuviTal wins Roche-backed breast cancer innovation challenge - JNS.org

المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.